These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 7793977)

  • 1. Functional assessment of specific amino acid residues of cytochrome P4501A1 using anti-peptide antibodies.
    Shen S; Strobel HW
    Arch Biochem Biophys; 1995 Jun; 320(1):162-9. PubMed ID: 7793977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Probing the putative cytochrome P450- and cytochrome c-binding sites on NADPH-cytochrome P450 reductase by anti-peptide antibodies.
    Shen S; Strobel HW
    Biochemistry; 1994 Jul; 33(29):8807-12. PubMed ID: 8038172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of LYS271 and LYS279 residues in the interaction of cytochrome P4501A1 with NADPH-cytochrome P450 reductase.
    Cvrk T; Strobel HW
    Arch Biochem Biophys; 2001 Jan; 385(2):290-300. PubMed ID: 11368010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of THR501 residue in substrate binding and catalytic activity of cytochrome P4501A1.
    Cvrk T; Strobel HW
    Arch Biochem Biophys; 2001 May; 389(1):31-40. PubMed ID: 11370669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Photoaffinity labeling of cytochrome P4501A1 with azidocumene: identification of cumene hydroperoxide binding region.
    Cvrk T; Strobel HW
    Arch Biochem Biophys; 1998 Jan; 349(1):95-104. PubMed ID: 9439587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and characterization of cytochrome P4501A1 amino acid residues interacting with a radiolabeled photoaffinity diazido-benzphetamine analogue.
    Cvrk T; Hodek P; Strobel HW
    Arch Biochem Biophys; 1996 Jun; 330(1):142-52. PubMed ID: 8651689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of lysine and arginine residues of cytochrome P450 in the interaction between cytochrome P4502B1 and NADPH-cytochrome P450 reductase.
    Shen S; Strobel HW
    Arch Biochem Biophys; 1993 Jul; 304(1):257-65. PubMed ID: 8323289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetic studies on a genetically engineered fused enzyme between rat cytochrome P4501A1 and yeast NADPH-P450 reductase.
    Sakaki T; Kominami S; Takemori S; Ohkawa H; Akiyoshi-Shibata M; Yabusaki Y
    Biochemistry; 1994 Apr; 33(16):4933-9. PubMed ID: 8161554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and characterization of an NADPH-cytochrome P450 reductase derived peptide involved in binding to cytochrome P450.
    Nadler SG; Strobel HW
    Arch Biochem Biophys; 1991 Nov; 290(2):277-84. PubMed ID: 1929397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of cytochrome P450 lysine residues in the interaction between cytochrome P450IA1 and NADPH-cytochrome P450 reductase.
    Shen S; Strobel HW
    Arch Biochem Biophys; 1992 Apr; 294(1):83-90. PubMed ID: 1550361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-function analysis of human CYP3A4 using a specific proinhibitory antipeptide antibody.
    Schulz-Utermoehl T; Mountfield RJ; Bywater RP; Madsen K; Jørgensen PN; Hansen KT
    Drug Metab Dispos; 2000 Jul; 28(7):718-25. PubMed ID: 10859142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a common cytochrome P450 epitope near the conserved heme-binding petide with antibodies raised against recombinant cytochrome P450 family 2 proteins.
    Soucek P; Martin MV; Ueng YF; Guengerich FP
    Biochemistry; 1995 Dec; 34(49):16013-21. PubMed ID: 8519757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrostatic interaction between cytochrome P450 and NADPH-P450 reductase: comparison of mixed and fused systems consisting of rat cytochrome P450 1A1 and yeast NADPH-P450 reductase.
    Kondo S; Sakaki T; Ohkawa H; Inouye K
    Biochem Biophys Res Commun; 1999 Apr; 257(2):273-8. PubMed ID: 10198202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential roles of Glu318 and Thr319 in cytochrome P450 1A2 catalysis supported by NADPH-cytochrome P450 reductase and tert-butyl hydroperoxide.
    Hiroya K; Murakami Y; Shimizu T; Hatano M; Ortiz de Montellano PR
    Arch Biochem Biophys; 1994 May; 310(2):397-401. PubMed ID: 7910007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epitope mapping studies with human anti-cytochrome P450 3A antibodies.
    Leeder JS; Gaedigk A; Lu X; Cook VA
    Mol Pharmacol; 1996 Feb; 49(2):234-43. PubMed ID: 8632755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short synthetic peptides exploited for reliable and specific targeting of antibodies to the C-termini of cytochrome P450 enzymes.
    Edwards RJ; Singleton AM; Murray BP; Davies DS; Boobis AR
    Biochem Pharmacol; 1995 Jan; 49(1):39-47. PubMed ID: 7840781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal antibody-directed characterization of rat hepatic P450 catalyzing the omega-1 and omega-2 hydroxylation of prostaglandins.
    Holm KA; Park SS; Gelboin HV; Kupfer D
    Arch Biochem Biophys; 1989 Mar; 269(2):664-77. PubMed ID: 2919889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Site-directed mutagenesis of putative substrate recognition sites in cytochrome P450 2B11: importance of amino acid residues 114, 290, and 363 for substrate specificity.
    Hasler JA; Harlow GR; Szklarz GD; John GH; Kedzie KM; Burnett VL; He YA; Kaminsky LS; Halpert JR
    Mol Pharmacol; 1994 Aug; 46(2):338-45. PubMed ID: 8078495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanistic studies of 9-ethynylphenanthrene-inactivated cytochrome P450 2B1.
    Roberts ES; Ballou DP; Hopkins NE; Alworth WL; Hollenberg PF
    Arch Biochem Biophys; 1995 Nov; 323(2):303-12. PubMed ID: 7487092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Requirements for cytochrome b5 in the oxidation of 7-ethoxycoumarin, chlorzoxazone, aniline, and N-nitrosodimethylamine by recombinant cytochrome P450 2E1 and by human liver microsomes.
    Yamazaki H; Nakano M; Gillam EM; Bell LC; Guengerich FP; Shimada T
    Biochem Pharmacol; 1996 Jul; 52(2):301-9. PubMed ID: 8694855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.